Malaria: all 1,315 studies
Page 10 of 14. Open to participants first (86), then studies with results posted, then the rest; newest registration first within each.
- Preventing the Spread of Malaria in MaliCompletedNCT01360112
- Safety and Immunogenicity of Malaria Vaccines AdCh63 AMA1, MVA AMA1 and AMA1-C1/Alhydrogel®+/- CPG 7909CompletedNCT01351948Phase 1
- Tracking Resistance to Artemisinin (TRAC)CompletedNCT01350856Phase 4
- Research on the Economics of Artemisinin Combination Therapy (ACTs) for the Treatment of MalariaCompletedNCT01350752Not applicable
- Proof-of-Concept Study of MSP3-LSP Vaccine to Protect Against Malaria in AfricaCompletedNCT01341704Phase 2
- Pharmacokinetics of Sulfadoxine-pyrimethamine Plus Amodiaquine for Intermittent Preventive Treatment in Children (IPTc)CompletedNCT01328990Phase 1/2
- Efficacy of Artemether-lumefantrine, Artesunate-amodiaquine and Dihydroartemisinin-piperaquine for the Treatment of Uncomplicated Plasmodium Falciparum Malaria in MalawiCompletedNCT01326754Not applicable
- Time to Become Negative of Three Rapid Diagnostic Tests for MalariaCompletedNCT01325974
- A Longitudinal Systems Biological Analysis of Naturally Acquired Malaria Immunity in MaliCompletedNCT01322581
- Intermittent Preventive Treatment for Malaria in Patient With Sickle Cell DiseaseCompletedNCT01319448Phase 1/2
- Prenatal Iron and Malaria StudyCompletedNCT01308112Phase 4
- A Cluster-randomised Trial of Interventions to Improve Antimalarial Prescribing With Malaria TestsCompletedNCT01292707Not applicable
- Study of ACTs Plus Primaquine for Uncomplicated Plasmodium Vivax MalariaCompletedNCT01288820Phase 3
- Worm Infestation and Child Health in ZimbabweCompletedNCT01283165
- Malaria Active Epidemiology and Treatment StudyCompletedNCT01280162Not applicable
- Malaria Surveillance in Rakai, UgandaCompletedNCT01265407
- Impact of IPT With Sulfadoxin Pyrimetamin on Pregnant Women and Their Babies Outcomes in Peri-urban Areas of Bobo-Dioulasso(Burkina Faso)CompletedNCT01255605
- Inhaled Nitric Oxide for the Adjunctive Therapy of Severe Malaria: a Randomized Controlled TrialCompletedNCT01255215Phase 1/2
- Plasmodium Falciparum Clearance Rates in Response to Artesunate in Eastern CambodiaCompletedNCT01240603
- Experimental Human Malaria Infection After Immunization With Plasmodium Falciparum Sporozoites Under Chloroquine ProphylaxisCompletedNCT01236612Not applicable
- Pharmacovigilance for ACTs in AfricaCompletedNCT01232530
- School Based Malaria Control in Ugandan SchoolchildrenCompletedNCT01231880Phase 3
- Efficacy,Safety and Tolerability of Dihydroartemisinin-Piperaquine for Uncomplicated Malaria in Pregnancy in GhanaCompletedNCT01231113Phase 3
- Surveillance of Effectiveness/Safety of Artemether-lumefantrine in Patients With MalariaCompletedNCT01228344
- Immunization With Different Doses of Plasmodium Falciparum Sporozoites Under Chloroquine ProphylaxisCompletedNCT01218893Not applicable
- Correlating Protection Against Malaria With Serum Profiles Against Plasmodium Falciparum Antigen RepertoiresCompletedNCT01214876
- Long-term Iron Supplements and Malaria Risk in Early Pregnancy: a Randomized Controlled TrialCompletedNCT01210040Not applicable
- G6PD (Glucose-6-phosphate Dehydrogenase) Study to Evaluate Hemolysis Potential of TFQ (Tafenoquine)CompletedNCT01205178Phase 1
- Efficacy of Artesunate-amodiaquine (AS-AQ) in Children With Malaria and Severe Acute Malnutrition, Madaoua, Niger 2010WithdrawnNCT01204411Phase 4
- Epidemiology of Burkitt Lymphoma in East Africa Children or Minors (EMBLEM)CompletedNCT01196520
- Introducing Rapid Diagnostic Tests Into the Private Health SectorCompletedNCT01194557Not applicable
- Have Malaria Infections in Kenya Become Less Responsive to Artemisinin Treatment?Status unknownNCT01190371Phase 4
- Sulphadoxine-Pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in UgandaWithdrawnNCT01184911Phase 4
- Estimating the Risk of Plasmodium Vivax Relapses in AfghanistanCompletedNCT01178021Phase 4
- EP1300 Polyepitope DNA Vaccine Against Plasmodium Falciparum MalariaCompletedNCT01169077Phase 1
- Zinc Supplementation to Reduce Diarrhea Rates in Adults in Western Kenya.CompletedNCT01166815Phase 2/3
- Study of Malaria Treatment at Phuoc Long Hospital, Binh Phuoc Province, VietnamCompletedNCT01165372Phase 2
- Iron Absorption and Utilization in Adolescents Infected With Malaria Parasites, Hookworms or SchistosomaCompletedNCT01163877Not applicable
- Effect of a Combined Use of Mosquito Repellent and Insecticide Treated Net on Malaria in EthiopiaCompletedNCT01160809Phase 4
- Pilot Study to Estimate the Burden and Distribution of Plasmodium Falciparum Malaria in Kalifabougou, Mali in Preparation for a Prospective Cohort Study of Naturally-Acquired Malaria ImmunityCompletedNCT01160562
- Artemether-Lumefantrine Effectiveness in Guinea-BissauCompletedNCT01157689
- Malaria and the Safety of Iron Supplements and Iron FortificationCompletedNCT01156896Not applicable
- Effectiveness of Nutritional Supplementation in Preventing Malnutrition in Children With InfectionCompletedNCT01154803Not applicable
- Antioxidant Micronutrients in MalariaCompletedNCT01152931Phase 3
- Evaluation of the Riamet® Versus Malarone® in the Treatment of Uncomplicated MalariaCompletedNCT01150344Phase 4
- Effectiveness of the Association Artesunate and Mefloquine in the Treatment of Malaria by Plasmodium FalciparumCompletedNCT01144702Phase 2/3
- Study to Assess Efficacy of New Malaria Vaccine Candidates AdCh63 AMA1, MVA AMA1, AdCh63 MSP1, MVA MSP1, AdCh63 ME-TRAP & MVA ME-TRAPCompletedNCT01142765Phase 1/2
- Artemether-Lumefantrine Effectiveness in Guinea-Bissau 2CompletedNCT01133314
- IMPACT2: Monitoring Interventions to Improve Artemisinin-based Combination Therapy (ACT) Access and TargetingStatus unknownNCT01130155
- Pharmacokinetics and Pharmacodynamics of Intravenous Artesunate for Severe Malaria TreatmentStatus unknownNCT01122134
- Assessment of Sulphadoxine-pyrimethamine for Intermittent Preventive Treatment of Malaria in Pregnancy in MalawiCompletedNCT01120145
- Prenatal Iron Supplements: Safety and Efficacy in TanzaniaCompletedNCT01119612Not applicable
- Malaria in Pregnancy: Nutrition and Immunologic EffectsCompletedNCT01115478Not applicable
- Artesunate+Sulfadoxine-Pyrimethamine for the Treatment of Uncomplicated Falciparum MalariaCompletedNCT01115439
- Study of Iron Absorption and Utilization in Asymptomatic MalariaCompletedNCT01108939Early Phase 1
- Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Vivax in Pregnancy in Brazil (PAACT-PV)TerminatedNCT01107145Phase 4
- Safety Study on the Effect of Eurartesim™ on QT/QTc Interval Compared to Riamet in Healthy VolunteersCompletedNCT01103830Phase 1
- A Phase 1 Study To Estimate The Relative Bioavailability Of Co-Administered Formulations Of Azithromycin Microsphere And Chloroquine Test Formulation Compared With Co-Administered Immediate Release Individual Azithromycin And Chloroquine Tablets In Healthy Adult SubjectsCompletedNCT01100060Phase 1
- A Study of AdCh63 AMA1 Alone and With MVA AMA1CompletedNCT01095055Phase 1
- Experimental Human Malaria Infection by PfSPZCompletedNCT01086917Phase 1
- Intermittent Preventive Treatment Versus Scheduled Screening and Treatment of Malaria in PregnancyCompletedNCT01084213Phase 4
- Establishment of a Sporozoite Challenge Model for Plasmodium Vivax in Human VolunteersCompletedNCT01083095Early Phase 1
- Efficacy of Artemisinin Combination Therapies for the Treatment of Uncomplicated P. Falciparum in Pregnancy in BrazilTerminatedNCT01082731Phase 4
- Pharmacokinetics of Mefloquine-Artesunate in Pregnant Women With Uncomplicated Plasmodium Falciparum InfectionWithdrawnNCT01082718Phase 2/3
- Assessing the Efficacy of Artemisinin Combination Therapies for Treatment of Uncomplicated Malaria Infection in ChildrenCompletedNCT01082705Phase 3
- Immunization of Human Volunteers With P. Vivax Irradiated SporozoitesCompletedNCT01082341Phase 1/2
- Safety and Immunogenicity Study of Plasmodium Vivax CS Derived Synthetic Peptides Formulated in Two AdjuvantsCompletedNCT01081847Phase 1
- The Sero-Prevalence and Genetic Study for the Infectious Diseases and Metabolic Syndrome in Solomon IslandsCompletedNCT01080989Not applicable
- Incidence of Vivax Along the Thai Burma BorderCompletedNCT01076868Not applicable
- Dihydroartemisinin- Piperaquine Versus Artemether- Lumefantrine in the Treatment Uncomplicated Plasmodium Falciparum Malaria in SudanStatus unknownNCT01075945Phase 4
- Study on the Treatment of Vivax MalariaCompletedNCT01074905Phase 3
- Artemether-Lumefantrine (AL) Unit Dose Pre-packs Versus Blister PacksCompletedNCT01065116Phase 3
- Malaria Survey in Mbarara District, Uganda 2010CompletedNCT01062386
- Reproducibility of Malaria Challenge in Healthy VolunteersCompletedNCT01058226Phase 1
- Randomised Trial of 3 Artemisinin Combination Therapy for Malaria in PregnancyCompletedNCT01054248Phase 3
- Establishing Effectiveness of Daily Co-trimoxazole Prophylaxis For Prevention of Malaria in PregnancyCompletedNCT01053325Phase 3
- Ethiopia Malaria Therapeutic Efficacy StudyCompletedNCT01052584Not applicable
- Role and Effectiveness of Rapid Diagnostic Tests in Home-based Management of MalariaCompletedNCT01048801Not applicable
- Evaluation of Insecticide Treated Nets and Wall Liners for the Prevention of MalariaCompletedNCT01043796Phase 3
- Non-malarial Febrile Illness in Children in Areas of Perennial Malaria TransmissionCompletedNCT01043744Not applicable
- Safety and Effectiveness of Artemisinin-based Combination Therapies (ACTs) With Repeated Treatments for Uncomplicated Falciparum Malaria Over a Three-year PeriodStatus unknownNCT01038063Phase 4
- Trial to Assess the Efficacy of Malaria Vaccine PfCS 102CompletedNCT01031524Phase 1/2
- Impact of Host Iron Status and Iron Supplement Use on Erythrocytic Stage of Plasmodium FalciparumCompletedNCT01027663Not applicable
- EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-immune AdultsCompletedNCT01026246Phase 1
- Impact of Enhanced Health Facility Care in UgandaCompletedNCT01024426Phase 4
- Artesunate Plus Amodiaquine in Malaria in Cote d'IvoireCompletedNCT01023399Phase 4
- Extended-dose Chloroquine (ECQ) for Resistant Falciparum Malaria Among Afghan Refugees in PakistanCompletedNCT01019408Phase 4
- Adenovirus Type 35 Based Circumsporozoite Malaria Vaccine in Burkina FasoCompletedNCT01018459Phase 1
- Artemether-lumefantrine (AL) Versus Artesunate + Amodiaquine (ASAQ) for the Treatment of Uncomplicated Falciparum Malaria in Burkina FasoCompletedNCT01017770Phase 4
- A Study of the Safety and Effectiveness of Two New Malaria VaccinesCompletedNCT01003314Phase 1/2
- Comparison of Three Plasmodium Falciparum Isolates in an Experimental Human Malaria InfectionCompletedNCT01002833Not applicable
- Fosmidomycin With Clindamycin or With Clindamycin Plus ArtesunateWithdrawnNCT01002183Phase 2
- Effectiveness Of Rapid Diagnostic Tests in the New Context of Low Malaria Endemicity in ZanzibarCompletedNCT01002066
- Treatment of Iron Deficiency Anemia in Malaria Endemic GhanaCompletedNCT01001871Not applicable
- Clinical Trial of the PfSPZ VaccineCompletedNCT01001650Phase 1
- Dose Ranging Study of Ferroquine With Artesunate in African Adults and Children With Uncomplicated Plasmodium Falciparum MalariaTerminatedNCT00988507Phase 2
- A Study to Assess Safety, Immunogenicity and Parasite Growth Inhibition of an Asexual Blood Stage Vaccine for P. Falciparum MalariaCompletedNCT00984763Phase 1/2
- Safety and Efficacy Study of Artesunate and Mefloquin in Children With Uncomplicated MalariaCompletedNCT00978172Phase 4
- Phase 1 Study of the Safety and Immunogenicity of a Malaria Transmission-blocking Pfs25-Pfs25 Conjugate VaccineWithdrawnNCT00977899Phase 1
- Prevention of Pregnancy-associated Malaria in HIV-infected Women: Cotrimoxazole Prophylaxis Versus MefloquineCompletedNCT00970879Phase 3